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Abstract
Background: Campylobacter jejuni is a major bacterial cause of food-borne enteritis, and its lipooligosaccharide
(LOS) plays an initiating role in the development of the autoimmune neuropathy, Guillain-Barré syndrome, by
induction of anti-neural cross-reactive antibodies through ganglioside molecular mimicry.
Results: Herein we describe the existence and heterogeneity of multiple LOS forms in C. jejuni strains of human
and chicken origin grown at 37°C and 42°C, respectively, as determined on sodium dodecyl sulphate-
polyacrylamide electrophoresis gels with carbohydrate-specific silver staining and blotting with anti-ganglioside
ligands, and confirmed by nuclear magnetic resonance (NMR) spectroscopy. The C. jejuni NCTC 11168 original
isolate (11168-O) was compared to its genome-sequenced variant (11168-GS), and both were found to have a
lower-Mr LOS form, which was different in size and structure to the previously characterized higher-Mr form
bearing GM1 mimicry. The lower-Mr form production was found to be dependent on the growth temperature as
the production of this form increased from ~5%, observed at 37°C to ~35% at 42°C. The structure of the lower-Mr
form contained a b-D-Gal-(1®3)-b-D-GalNAc disaccharide moiety which is consistent with the termini of the GM1,
asialo-GM1,G D 1,G T 1 and GQ1 gangliosides, however, it did not display GM1 mimicry as assessed in blotting studies
but was shown in NMR to resemble asialo-GM1. The production of multiple LOS forms and lack of GM1 mimicry
was not a result of phase variation in the genes tested of NCTC 11168 and was also observed in most of the
human and chicken isolates of C. jejuni tested.
Conclusion: The presence of differing amounts of LOS forms at 37 and 42°C, and the variety of forms observed in
different strains, indicate that LOS form variation may play a role in an adaptive mechanism or a stress response of
the bacterium during the colonization of different hosts.
Background
Campylobacter jejuni is now well established as the
leading cause of bacterial food-borne gastroenteritis
worldwide [1,2]. Infection symptoms vary in severity and
m a yi n c l u d en a u s e a ,s e v e r eo rb l o o d yd i a r r h e a ,a b d o m -
inal cramping and fever [3]. C. jejuni infection is usually
self-limiting, but in some cases may progress to the
debilitating, polyneuropathic disorders Guillain-Barré
syndrome (GBS) or the oculomotor variant Miller Fisher
syndrome (MFS) [4,5]. Importantly, C. jejuni is the com-
monest antecedent infection in these neuropathies and
expression of carbohydrate epitopes mimicking host
gangliosides is considered a prerequisite for neuropathy
development since such mimicry can induce pathogenic,
cross-reactive antibodies [6,7]. Gangliosides are glyco-
sphingolipids occurring in high concentration in the
peripheral nervous system, particularly in the nerve
axon [8]. A humoural response against these glycolipids
(e.g. anti-GM1,G M 1b,G D 1a,G a l N A c - G D 1a GT1a and
GQ1b antibodies) plays a central role in GBS and MFS
development [6,7]. Mimicry of the saccharide compo-
nent of gangliosides within the outer core of C. jejuni
lipooligosaccharides (LOS) is well documented [9,10].
Supporting a pathogenic role of C. jejuni in GBS,
C. jejuni LOS-induced anti-GM1 ganglioside antibodies
react at the nodes of Ranvier, where the axon is exposed
in the nerve fibre [11], resembling the pathology
observed in GBS patients, and inoculation of C. jejuni
* Correspondence: v.korolik@griffith.edu.au
1Institute for Glycomics, Griffith University, Gold Coast campus, Queensland,
Australia
Full list of author information is available at the end of the article
Semchenko et al. BMC Microbiology 2010, 10:305
http://www.biomedcentral.com/1471-2180/10/305
© 2010 Semchenko et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.GM1-mimicking LOS has been reported to induce GBS-
like symptoms in a rabbit model [12].
C. jejuni is capable of growth at temperatures ranging
from 30 to 47°C and therefore is capable of growth at
the body temperatures of human and avian hosts, 37
and 42°C, respectively [13,14]. Different temperature
environments may trigger events to accommodate the
colonization, commensalism, pathogenesis or dormancy
of this bacterium. Over 350 genes have been reported to
be differentially expressed at 37°C compared to 42°C,
including the galE and wlaE genes found in the LOS
biosynthesis locus [15]. Moreover, LOS is an important
pathogenic factor of C. jejuni.A r i s i n gf r o mt h i s ,i ti s
possible that C. jejuni LOS expression is affected by
temperature, whether it is by variable gene expression
or at the enzymatic activity level. Although mimicry of
gangliosides by C. jejuni LOS has been extensively stu-
died structurally over the last two decades [9,10], it is
i m p o r t a n tt on o t et h a tt h e s eprevious characterization
studies have been performed on strains grown at 37°C.
The human isolate C. jejuni NCTC 11168 has been a
basis for studying this bacterial species since the late
1970s. The sequencing and annotation of its genome was
published by the Sanger Centre [16]. A later study
revealed that the genome-sequenced strain of C. jejuni
NCTC 11168 (11168-GS) is a poor colonizer of 1 day-old
chicks and showed that this variant had an altered mor-
phology and a different transcriptional profile compared
with the original NCTC 11168 isolate (11168-O) [17].
Recurrent passaging of C. jejuni 11168-O in laboratory
conditions was considered responsible for this variation.
To date, a number of genes from the LOS biosynthesis
cluster of C. jejuni NCTC 11168 (HS:2) have been char-
acterized [4,18] and the structures of the lipid A and
saccharide components of the LOS have been reported
[19-21]. The LOS outer core mimics the oligosaccharide
(OS) region of GM1 ganglioside [20,21] and is likely to
be capable of switching from a GM1-like epitope to a
GM2-like epitope as a result of phase variation [22,23].
The lack of knowledge of the structure of C. jejuni
LOS at 42°C compared to 37°C prompted us to examine
the effect of incubation temperature on the phenotypic
variation of LOS, including the mimicry of gangliosides,
in C. jejuni 11168-GS and 11168-O. Variation in LOS
structure was assessed by electrophoretic analysis and
immunoblotting and confirmed by nuclear magnetic
resonance (NMR) spectroscopy. Carbohydrate epitopes
produced by both strains were assessed for ganglioside
mimicry using various anti-ganglioside ligands (i.e. anti-
bodies, lectins and cholera toxin) as probes. In addition,
LOS structural variation at these two incubation tem-
peratures was examined in minimally subcultured C.
jejuni isolates from humans and chickens. Importantly,
notable differences were observed in the relative
production by C. jejuni of varying size and ganglioside
mimicries at 37°C and 42°C.
Results
Electrophoretic analysis of C. jejuni LOS preparations
Mini-preparations of LOS isolated from C. jejuni 11168-
GS and 11168-O strains grown at 37°C and 42°C were
examined using sodium dodecyl suphate-polyacrylamide
gel electrophoresis (SDS-PAGE) analysis. The LOS from
C. jejuni 11168-O and 11168-GS strains resolved into
two distinct forms, referred to from here on as higher-Mr
and lower-Mr LOS (Figure 1b). Two control LOS with a
known size (Figure 1a) from M. catarrhalis serotype A
(strain 2951) were used for relative sizing of C. jejuni
LOS. The first was wild-type LOS and resolved on the
SDS-PAGE with the lower band at ~4 kDa (lane 1). The
second was a LOS from a lgt4 mutant (2951Δlgt4)o f
M. catarrhalis 2951, lacking one glucose and resolved at
~3 kDa [24] (lane 2). Therefore, the difference of one
hexose unit corresponded to a relative migration of ~1
kDa. Accordingly, these controls were used to compare
the sizes of the C. jejuni LOS forms (Figure 1b and 1c).
The higher-Mr form of C. jejuni LOS resolved at approxi-
mately 6 kDa (and corresponds to the previously
described LOS bearing GM1 mimicry [20-23]), whereas
the lower-Mr form, which has not been previously
reported, was observed at ~4 kDa. Figure 1b shows that
C. jejuni 11168-O (lanes 3 and 4) and 11168-GS (lanes 5
and 6) have a greater amount of the 4 kDa LOS form at
42°C, than at 37°C. For both 11168-O and -GS at 42°C
the amount of LOS produced appears greater than at
37°C, both in terms of quantity of the 6 kDa form and
t h e4k D af o r m .D e n s i t o m e t r yanalysis revealed that for
11168-O at 37°C (Figure 1b, lane 3) 6.3% of the total LOS
produced was the 4 kDa form and 93.7% was the 6 kDa
form. In contrast, at 42°C 35.5% of total LOS produced
was the 4 kDa form and 64.5% was the 6 kDa form. Simi-
lar results were observed for 11168-GS variant. These
results were confirmed using purified LOS preparations
from C. jejuni 11168-O and 11168-GS, which gave identi-
cal electrophoretic profiles (data not shown) as those of
the LOS mini-preparations. Also, the total amount of
protein isolated from the same cell populations of
C. jejuni 11168-O and C. jejuni 11168-GS were unaf-
fected by the change of growth temperature (data not
shown), thus allowing normalisation of cell samples prior
to proteinase K digestion to produce LOS mini-prepara-
tions for comparison. In contrast to LOS, the CPS pro-
files from the same populations were unaffected by
change of growth temperature (data not shown).
The LOS of the wild-type human isolate C. jejuni 520
was analysed identically (Figure 1c) to determine whether
the temperature-related phenomenon was unique to
C. jejuni NCTC 11168. The LOS of strain 520 was found
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and lower-Mr LOS form. The relative LOS form profile of
C. jejuni 520 was also noted to be affected by growth tem-
perature (Figure 1b), whereby a slightly greater amount of
the lower-Mr LOS was produced at 42°C (lane 2).
NMR spectroscopic analysis of the higher-Mr and lower-
Mr LOS form of C. jejuni 111168 at 42°C
Analysis of the OS isolated from C. jejuni 11168-O at
37°C with 1D NMR gave spectra (data not shown) con-
sistent with the previously published structure of
C. jejuni NCTC 11168 [20,21] (Figure 2). Given that the
previous structural studies of C. jejuni NCTC 11168
core OS [20,21] had been performed on bacteria grown
at 37°C it was of interest to investigate the differences in
the core OS structure that were observed at 42°C. To
this end, bacteria were grown at 42°C, the LOS
extracted and purified, and the core OS acid-liberated.
Examination of the
31P spectrum of the OS so obtained,
showed a single
31P peak at ~0 ppm, and which was
confirmed from a heteronuclear single quantum coher-
ence (HSQC)-total correlation spectroscopy (TOCSY)
spectrum to be a phosphorylethanolamine (PEtn) resi-
d u e .D o u b l i n gu po ft h ea n o m e r i cl i n eo ft h es i g n a l
attributed substitution to the ®3,4,6)-L-a-D-Hep- (C)
which is probably due to some heterogeneity in the
phosphorylation of the heptose (see Figure 2). Signals
consistent with a-linked N-acetylneuraminic acid
(a-Neu5Ac, sialic acid), and N-acetylgalactosamine (Gal-
NAc) were also noted. Furthermore, the anomeric
region of the HSQC spectrum revealed the presence of
nine anomeric signals, in addition to the a-Neu5Ac.
Taken together, these spectra were consistent with the
previously published structure of C. jejuni NCTC 11168
grown at 37°C [21] as shown in Figure 2. Nevertheless,
examination of the NMR spectra of another isolated
minor fraction of the core OS of 11168-O grown at
42°C revealed that there was heterogeneity in the frac-
tions with regards to the sialylation of residue (G). Two
separate regions of the 1D
1Ha r es h o w ni nF i g u r e3 ;a
portion of the anomeric region (5.56-5.70 ppm) and the
region of the spectrum where the H3eq protons of a-
Neu5Ac are expected (2.65-2.85 ppm). Spectrum 3a
shows the major fraction consistent with that published
in [21]. In spectrum 3b, the anomeric proton found at
5.67 ppm (residue A) is doubled up and there is a con-
comitant decrease in the signal intensity of H3eq pro-
tons of Neu5Ac. The anomeric resonance of A is
distinct from the other anomeric resonances and conve-
niently provides a monitor of the structure of the OS in
its vicinity. It is expected that the chemical shift of the
anomeric resonance of A would be affected by differ-
ences in the sialylation of the galactose (Gal) residue
(G). Accordingly, in the minor fraction, which has less
sialylation of residue (G), there is the appearance of a
new anomeric signal of residue A at 5.64 ppm.
Figure 1 Silver-stained SDS-PAGE gel of the LOS extracted from C. jejuni NCTC 11168 and 520. (a) Controls of M. catarrhalis serotype A
(strain 2951) LOS for relative sizing LOS. Lanes: 1, M. catarrhalis wild-type LOS (WT); 2, M. catarrhalis M¯mutant LOS lacking the terminal glucose;
(b) C. jejuni 11168-O and 11168-GS LOS extracted from bacteria grown at 37°C and 42°C. Lanes: 3, 11168-O at 37°C; 4, 11168-O at 42°C; 5, 11168-
GS at 37°C; 6, 11168-GS at 42°C. (b) C. jejuni 520 LOS extracts from bacteria grown at 37°C and 42°C. Lanes: 1, 520 at 37°C; 2, 520 at 42°C. Higher-
Mr LOS resolved at ~6 kDa and lower-Mr LOS at ~4 kDa.
Figure 2 C. jejuni NCTC 11168 core OS structure. Shown is the structure of the higher-Mr LOS form [20,21], the lower-Mr form can lack the
Neu5Ac residue thereby producing an asialo-GM1 mimic. Abbreviations: Gal, galactose; GalNAc, N-acetylgalactosamine; Glc, glucose; Hep,
heptose; Neu5Ac, N-acetylneuraminic acid Kdo, 3-deoxy-D-manno-oct-2-ulosonic acid; PEtn, phosphorylethanolamine.
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ence in sialylation between the higher-Mr form of C. jejuni
11168 LOS (~6 kDa) and the lower-Mr form (~4 kDa); in
the latter Neu5Ac can be absent, thus exhibiting asialo-
GM1 mimicry. Sialic acid is a 9-carbon sugar and has dif-
ferent charge properties to hexose sugars, which accounts
for the approximately 2 kDa difference in apparent mass
of the two LOS forms as seen in Figure 1.
Analysis of GM1 epitope mimicry in C. jejuni LOS using
cholera toxin subunit B (CTB)
C. jejuni 11168-GS has been previously reported to
mimic the structure of the GM1 ganglioside and hence
displays strong binding to CTB [20-23,25]. Therefore, to
determine whether the higher- or lower-Mr LOS forms
of C. jejuni 11168-O and 11168-GS mimic the GM1 epi-
tope, the ability of both LOS forms to bind CTB was
analysed using a blotting assay. The higher-Mr LOS of
C. jejuni 11168-O and 11168-GS isolates grown at 37°C
or 42°C bound CTB strongly (Figure 4, lanes 1-4). On
the other hand, the lower-Mr LOS did not bind to CTB,
indicating that it does not exhibit GM1 mimicry. In con-
trast, the higher-Mr LOS form of C. jejuni strain 520
grown at 37°C or 42°C bound CTB weakly, indicating
that the saccharide terminus may exhibit some ganglio-
side-related mimicry, though probably not GM1. Binding
of CTB to the lower-Mr form was not detected (Figure
4, lanes 5 and 6).
Analysis of C. jejuni LOS epitope mimicry using peanut
agglutinin (PNA)
To further investigate the molecular mimicry of
C. jejuni 11168 LOS forms, lectin blotting was per-
formed using PNA which binds b-D-Gal-(1®3)-D-Gal-
NAc and b-D-Gal(1®3)-D-Gal. The disaccharide b-D-
Gal-(1®3)-D-GalNAc is present as the terminal disac-
charide of GM1 ganglioside, but is also present in other
gangliosides (e.g. asialo-GM1, GD1,G T 1 and GQ1 gang-
liosides). PNA strongly bound both the higher-Mr and
lower-Mr LOS forms of C. jejuni 11168-O and 11168-
GS grown at 37 and 42°C (Figure 5, lanes 1-4). Binding
of the PNA to the higher-Mr LOS is consistent with the
presence of GM1-like mimicry and CTB binding
observed above. Binding of PNA to the lower-Mr LOS is
also probably due to the occurrence of a terminal b-D-
Gal-(1®3)-D-GalNAc in the truncated lower-Mr LOS.
Taking the results of CTB and PNA together suggests
that the most likely structure for the lower-Mr LOS
form is an asialo-GM1-like structure.
In contrast, both higher-Mr and lower-Mr LOS of
C. jejuni 520 did not bind PNA (Figure 5; lanes 5-6) in
Figure 3
1H 1D spectrum (298 K, 600 MHz) of the C. jejuni
NCTC 11168 OS. (a) The major fraction. (b) The minor fraction. The
anomeric signal of residue A is shown (between 5.62 - 5.70 ppm)
and the H3eq proton of a-Neu5Ac (between 2.65-2.85 ppm).
Figure 4 Cholera toxin blot of the LOS extracts from C. jejuni
11168-O, 11168-GS and 520 grown at 37°C and 42°C. Lanes: 1,
11168-O at 37°C; 2, 11168-O at 42°C; 3, 11168-GS at 37°C; 4, 11168-
GS at 42°C; 5, 520 at 37°C; 6, 520 at 42°C. A control lane without
blotted material did not show reactivity (not shown). Positive
binding to the higher-Mr LOS, resolved at ~6 kDa.
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with the results of CTB-binding analysis of the LOS
with this strain and indicated the absence of GM1-like
mimicry, but does not exclude other ganglioside mimi-
cry in the LOS forms of C. jejuni 520.
Analysis of LOS from C. jejuni NCTC 11168-O single
colonies
To determine whether the production of multiple LOS
forms occurs as a result of a phase variation, LOS mini-
preparations from 30 randomly selected, single colonies
of C. jejuni 11168-O grown at 37 or 42°C were analysed.
Higher- and lower-Mr LOS forms were present within
each clonal population of C. jejuni 11168-O grown at 37
or 42°C. Figure 6 shows a representative sample of LOS
profiles from single colonies grown at 42°C which
showed identical profiles with ~35.5% of the total LOS
produced being of 4 kDa form and ~64.5% of the 6 kDa
form. LOS profiles for single C. jejuni 11168-O colonies
grown at 37°C were also identical to each other and to
that shown in Figure 1b, lane 3 (data not shown).
Equally strong binding of CTB to higher-Mr LOS was
observed for all the colonies tested suggesting that the
phenomenon is unlikely to have been caused by phase
variation. This was further confirmed by DNA sequence
analysis of homopolymeric G- and A-tracts in wlaN and
cj1144-45c genes as described below.
The observed GM1 mimicry of the LOS epitope was
also confirmed by a colony lift whereby each of the sin-
gle colonies of C. jejuni 11168-O grown at 37°C was
found to bind the GM1-binding ligand CTB (data not
shown).
Analysis of the homopolymeric tracts from the phase
variable genes wlaN and cj1144-45c in C. jejuni NCTC
11168-O single colonies
To further examine the nature of LOS variation in
C. jejuni, gene expression of the homopolymeric regions
of two known phase variable genes, wlaN (responsible
for addition of terminal Gal to OS [23]) and cj1144-45c
(function unknown), located in the LOS biosynthesis
locus of C. jejuni were analysed. Both genes were ampli-
fied from 20 randomly selected single colonies of
C. jejuni 11168-O grown at 42°C and were subsequently
sequenced. Each clonal population contained an 8-resi-
due G-tract in the wlaN, which allows for complete
translation of the gene. The sequence of c1144-45c was
consistently found to contain a 9-residue G-tract which
interrupts the reading frame. In addition, a homopoly-
meric A-tract of cj1144-45c was also examined and no
sequence variation could be detected in any of the clo-
nal populations. As further confirmation of the lack of
phase variation in the wlaN and cj1144-45c genes, the
total bacterial cell population from a confluent agar
plate, was subjected to similar polymerase chain reaction
(PCR) analysis and sequence analysis and consistently
only a single sequence for each homopolymeric tract
was detected. These analyses confirmed that the growth
temperature did not induce sequence variation in the
lengths of the homopolymeric G-tract and A-tract in
cj1144-45c as well as in the G-tract of wlaN of C. jejuni
11168-O.
LOS form variation in human and chicken isolates of
C. jejuni
C. jejuni strains originally isolated from human patients
and broiler chickens were examined to determine
whether multiple LOS forms are common in Campylo-
bacter strains (Table 1). Figure 7a illustrates the diver-
sity of the LOS forms observed in extracts from a
representative selection of human and chicken isolates
of C. jejuni from those listed in Table 1. C. jejuni
chicken isolates strains 331, 434, 506, 7-1 and RM1221
expressed both higher and lower-Mr LOS forms whereas
in strains 913, 019 and 008 only the higher-Mr LOS
form was detected (Table 1). All the human isolates
Figure 5 PNA lectin blot of the LOS extracts from C. jejuni
11168-O, 11168-GS and 520 grown at 37°C and 42°C. Lanes: 1,
11168-O at 37°C; 2, 11168-O at 42°C; 3, 11168-GS at 37°C; 4, 11168-
GS at 42°C; 5, 520 at 37°C; 6, 520 at 42°C. A control lane without
blotted material did not show reactivity (not shown). Positive
binding to higher-Mr LOS resolved at ~6 kDa and lower-Mr LOS at
~4 kDa.
Figure 6 Silver-stained SDS-PAGE gel of LOS extracted from
single colonies of C. jejuni 11168-O grown at 42°C. Lanes: 1-3,
LOS from selected individual colonies. Higher-Mr resolved at ~6 kDa
and lower-Mr LOS observed at ~4 kDa.
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forms except for strain 375 where only one Mr form
(higher- Mr form) was detected (Table 1). C. jejuni
strains 331 (chicken), 434 (chicken), 224 (human), 421
(human) and 11168 (human) were also shown to
increase the production of lower-Mr LOS form, and a
corresponding total increase in LOS production, at 42°C
in contrast to 37°C (Table 1).
A CTB blot of LOS from a representative selection of
h u m a na n dc h i c k e ni s o l a t e so fC. jejuni (Figure 7b),
demonstrated the variability in LOS expression in differ-
ent strains with respect to ganglioside mimicry. Only
the higher-Mr LOS form was found to bind CTB in the
tested strains. Furthermore, the higher-Mr LOS of some
C. jejuni strains (506 and 913) did not bind CTB, indi-
cating the absence of GM1 ganglioside mimicry in both
forms of LOS.
Discussion
This study has shown that C. jejuni NCTC 11168-O and
11168-GS, as well as most randomly chosen chicken and
human strains produce at least two distinct LOS forms
when incubated at the core temperatures of human (37°C)
and avian (42°C) hosts. This is consistent with previous
observations that C. jejuni is capable of producing a variety
Table 1 Summary of the LOS phenotypes from different
C. jejuni isolates
Origin C. jejuni
strain
LOS phenotype at
37°C
LOS phenotype at
42°C
chicken 331* H, L H, L￿
434 H, L H, L￿
506* H, L H, L
913* H H
008 H H
019 H H
7-1 H, L H, L
RM1221 H, L H, L
human 224* H, L H, L￿
291 H, L H, L
351 H, L H, L
375 H H
388 H, L H, L
421* H, L H, L￿
520 H, L H, L
11168-GS* H, L H, L￿
81116 H, L H, L
H, higher-Mr LOS form.
L, lower-Mr LOS form.
￿ Increase in the amount of LOS produced.
*Shown in Figure 7.
Figure 7 Analysis of the LOS extracts from C. jejuni strains of human and chicken origin grown at 37 and 42°C. (a) Silver-stained SDS-
PAGE gel. (b) CTB blot of LOS extracts resolved as in (a). Lanes: 1, 11168-O at 37°C; 2, 11168-O at 42°C; 3: 224 at 37°C; 4, C. jejuni 224 42°C; 5, C.
jejuni 331 37°C; 6, C. jejuni 331 42°C; 7, C. jejuni 421 37°C; 8, C. jejuni 421 42°C; 9, C. jejuni 506 37°C; 10, C. jejuni 506 42°C; 11, C. jejuni 913 37°C; 12,
C. jejuni 913 42°C. A control lane without blotted material did not show reactivity (not shown). Positive binding of the CTB to the higher-Mr LOS
resolved at ~6 kDa.
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growth conditions, such as temperature [26].
Surface antigen modulation and generation of host-
adapted variants are common attributes of many bac-
teria and enhance the pathogenicity and survivability of
t h em i c r o o r g a n i s m ,a sw e l la st h ea b i l i t yt oe v a d et h e
host immune response during the infection [27]. This
variation may be achieved through several mechanisms,
such as differential gene expression or enzymatic activity
and specificity modulation, which can be triggered by a
random and/or environmental stimuli [28]. It is possible
to speculate that in the case of C. jejuni LOS, glycosyl
transferases have the highest activity or are more stable
promoting maximum functionality.
It is interesting to note that the growth temperature of
C. jejuni NCTC 11168 was previously reported to influ-
ence the oxidative stress response [14]. In addition,
approximately 20% of C. jejuni genes were reported to be
up- or down-regulated in response to increasing the tem-
perature from 37 to 42°C, including genes from the LOS
and protein glycosylation clusters [15]. However, the
change in LOS phenotype was not resolved to date.
In the present study, the phenotypic expression of the
lower-Mr LOS form appeared to be modulated by
the growth temperature. This prompts speculation that
the increased production of this form may be directly or
indirectly caused by either specific changes in gene
expression of the glycosyltransferases or glycosyl synth-
esis genes affecting LOS biosynthesis, thus leading to the
production of varying amounts of the LOS forms. Due to
the apparent loss of sialylation in the lower Mr LOS
structure it is likely that the variation of the structure is
attributable to functional differences in the synthesis of
the transport machinery of sialic acid under the different
temperatures. We consider the most likely candidate for
this difference to be the dual functioning enzyme, Gal-
NAc transferase and CMP-Neu5Ac synthase, CgtA [18].
It is also tempting to speculate that the increased pro-
duction of the lower-Mr LOS form at 42°C might play a
role in the bacterial-host interactions of C. jejuni.T h e
increased production of the 4 kDa form which occurred
at 42°C, the avian host body temperature, raises a possi-
bility that this form could contribute to the commensal-
i s mb yt h i sb a c t e r i u mi np o u l t r y[ 1 7 ] .T h ei n c r e a s ea t
37°C in the proportion of the higher Mr LOS, the por-
tion of the LOS that is sialylated and is a GM1 mimic
[20,21], indicates an increase in the production of an
LOS structure that is thought to have a role in immune
evasion and survival in mammalian hosts [29]. These
hypotheses, however, will require further investigation,
particularly chicken and murine infection studies.
Phase variation is the most commonly described
mechanism, for antigenic variation and changes in the
phenotype of the microorganism. Like Neisseria
meningitidis and Haemophilus influenzae, C. jejuni is
also known to exhibit modulation of its surface polysac-
charide structures as a result of phase variation [27,30];
however, this does not appear to be the case with pro-
duction of the temperature-related LOS form in
C. jejuni. Both forms were consistently produced by all
clonal populations of C. jejuni 11168-O examined in
this study suggesting that modulation of LOS forms is
unlikely to be caused by phase variation. Furthermore,
we have analyzed the “on-off” status of phase variable
genes (wlaN and cj1144-45c)i nC. jejuni LOS biosynth-
esis cluster to further demonstrate that the described
variation of LOS forms is not being caused by phase
variation of LOS genes. C. jejuni 11168-O grown at 42°
C was used in this experiment as it shows greater abun-
dance of the lower-Mr LOS form, hence increasing the
chance of detecting changes in phase variable genes.
Lengths of the homopolymeric G and A tracts from
wlaN and cj1144-45c genes did not vary in any of 20
randomly selected colonies, suggesting that these genes
are under regulatory mechanisms unaffected by growth
temperature and the described variation of LOS forms is
not caused by variation in the lengths of the homopoly-
meric tracts. Furthermore, no change in the GM1 mimi-
cry of the clonal populations had been observed. It is
also interesting to note that not all strains of C. jejuni
expressed multiple LOS forms irrespective of the isola-
tion origin, human or chicken.
No differences were observed in the production of the
various LOS forms between the two variants of 11168,
the genome sequenced and original isolate. The higher-
Mr form of C. jejuni 11168 (~6 kDa) exhibited GM1-like
mimicry and, therefore, corresponded to the previously
characterized LOS [20,21,23]. Studies with CTB, a well-
known binder of GM1 ganglisoide [25], confirmed the
presence of a GM1 mimic in this form of NCTC 11168.
Similar mimicry was also detected among the higher-Mr
LOS forms of the other isolates of humans and chickens
tested, but not in the lower-Mr form of any other
strains. The weak binding of CTB to the higher-Mr LOS
variant of C. jejuni 520 reflects that the saccharide ter-
minus may exhibit some ganglioside-related mimic,
though not GM1 mimicry. This is shown by the CTB
binding to ganglioside-related structures not just GM1
and PNA did not confirm the presence of a terminal
b-D-Gal-(1®3)-D-GalNAc. A CTB binding affinity
study showed that the lower-Mr form of C. jejuni
NCTC 11168 failed to bind to the lectin. Nevertheless,
the results of the present study showed that it contains
a b-D-Gal-(1®3)-D-GalNAc disaccharide moiety in the
core consistent with production of a truncated (because
of its lower molecular mass), but related form, of the
NCTC 11168 structure previously described [21], and is
an asialo-GM1-like structure.
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In conclusion, this study identified the presence of a
lower-Mr LOS form produced by C. jejuni NCTC 11168
and other clinical and avian strains. The lower-Mr form
production was growth-temperature related as higher
quantities were observed at 42°C. It is tempting to specu-
late that the occurrence of greater quantities of this form
at avian body temperature might play a role in an adapta-
tive mechanism to aid commensal colonization of such
hosts. Alternatively, changes in the relative production of
the two forms of LOS at the higher temperature could be
related to a stress response. Such a phenomenon has
already been seen with increased oxygen tension in the
growth atmosphere of C. jejuni influencing the structural
mimicry exhibited in the LOS of this bacterium [31].
Although an intriguing phenomenon, further investiga-
tions are required to evaluate these alternate hypotheses.
Methods
Bacterial strains and growth conditions
The original isolate of C. jejuni NCTC 11168 (11168-O)
that had been characterized by Gaynor et al. (2004)
[17], C. jejuni 11168-GS (genome-sequenced NCTC
11168) that had been sequenced and annotated at the
Sanger Centre (Hinxton, Cambridge, UK) [16], and
strain 81116 were kindly supplied by D.J. Newell (Veter-
inary Laboratories Agency, Weybridge, UK). C. jejuni
RM1221 has been described [32] and was kindly pro-
vided by R. E. Mandrell (United States Department of
Agriculture, CA, USA.). C. jejuni clinical isolates 224,
291, 351, 375, 388, 421, 520, and chicken isolates 008,
019, 331, 434, 506, 913, 7-1 were obtained from the
Royal Melbourne Institute of Technology (Melbourne,
Vic., Australia) and Griffith University (Gold Coast,
Qld., Australia) culture collections. All C. jejuni strains
were subcultured no more than once to avoid the influ-
ence of passaging. Strains were grown on blood agar,
composed of Columbia agar containing 5% (v/v) defibri-
nated horse blood and Skirrow’s antibiotic supplement
(Oxoid), under microaerobic conditions (5% O2, 10%
CO2 and 85% N2) at 37°C for 48 h and 42°C for 24 h.
LOS preparations
For gel electrophoresis
Blood agar-grown bacteria were harvested in 1 mL of
sterile water, washed once in 1 mL of sterile water, and
lysed by heating. Prior to lysis, samples were adjusted
for numbers of bacteria using the OD600 measurements
of bacterial suspensions. Mini-preparations of LOS were
prepared by treating the whole-cell extracts with protei-
nase K as described previously [33]. The LOS mini-pre-
parations from single colonies were prepared by
collecting and washing cells in 40 μLo fs t e r i l ew a t e r
and then lysing by heating. Purified C. jejuni LOS was
prepared by subjecting the biomass to hot phenol-water
treatment using 90% (v/v) aqueous phenol at 65°C for
10 min [34]. Extracted LOS was purified by enzymatic
treatment as described previously [19]. The LOS pre-
parations were made up to 15 μg/μL in distilled water
prior to gel electrophoresis.
For NMR analysis
C. jejuni 11168 was grown for 24 hr as described above
and bacterial biomass was harvested and washed twice
using phosphate-buffered saline pH 7.4 (PBS; Sigma) and
centrifugation (5000 × g, 4°C, 15 min). Biomass was lyo-
philised and 21 g and 20 g dry-cell mass was collected
from cultures grown at 37°C and 42°C, respectively.
Dried biomass was pretreated using pronase-E [35].
Extraction of LOS was carried out using hot-phenol
water technique [34]. Water-soluble LOS was purified
using RNaseA, DNase II and proteinase K (Sigma) and
ultra-centrifugation, as previously described [19]. The
LOS were treated with 0.1 M HCl at 100°C for 2 hours to
cleave the acid-labile ketosidic linkage between the core
OS and lipid A [19]. The lipid A precipitate was removed
by centrifugation (5000 × g,4 ° C ,3 0m i n s ) ,w a s h e da n d
both this and supernatant were lyophilised. The superna-
tant was fractionated using gel-permeation chromatogra-
phy on a column of Bio-Gel P4 (1 m × 2 cm) with 0.05
M pyridinium acetate (pH 4.5) as the eluent. The resul-
tant fractions were monitored by capillary-tube spotting
on silica gel 60 TLC plates (Merck), followed by charring
with 20% H2SO4 in EtOH at 150°C. The water-soluble
carbohydrate-containing fractions of core OS were flash-
frozen in dry-ice/acetone bath and lyophilized.
CPS and whole-cell protein preparations
For assessing CPS production, proteinase K-treated
whole cell extracts were prepared as described above.
Whole-cell protein samples were prepared by incubating
SDS-PAGE loading buffer with C. jejuni biomass at 100°
C for 5 min to facilitate bacterial lysis and binding of
the SDS to the denatured proteins.
Electrophoretic analyses
Equal quantities of samples, either LOS mini-preparations
or purified LOS, and CPS samples were resolved on 10%
(v/v) SDS-PAGE containing urea (6 M) and tricine (0.3
mM) (Tricine-SDS-PAGE) with tricine-containing cathode
buffer as previously described [36]. Stacking and separat-
ing gels contained 5.5% and 10% (v/v) acrylamide, respec-
tively. Following the electrophoresis of LOS samples, gels
were fixed and the resolved molecules were detected using
the carbohydrate silver staining method [37] or CPS by
Alcian Blue staining [38]. Electrophoresis was conducted
at 30 V for 1 h to maximize stacking and then separated at
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resolved on glycine-buffered 15% (v/v) polyacrylamide
gels (Glycine-SDS-PAGE) as previously described [39].
Electrophoresis was conducted at 100 V for 1.5 h. Pro-
t e i n sw e r ed e t e c t e db yc o n v e n t i o n a lC o o m a s s i eB l u e
staining [19]. Densitometry image analysis was per-
formed using the QuantityOne software package (Bio-
Rad). The published M. catarrhalis LOS from M. cat-
arrhalis wild-type (strain 2951) and the lgt4 LOS bio-
s y n t h e s i sm u t a n t[ 2 4 ]w e r eu s e da sac o n t r o lf o r
relative size determination of LOS structures due to
the loss of a single hexose sugar from the known OS
structure.
NMR spectroscopy
Purified OSs were dissolved in D2O (CIL 99.998%) and
cycled through 3 steps of lyophilization/dissolution to
remove exchangeable protons.
1Ha n d
13CN M R
experiments were performed at 600 MHz and 150
MHz respectively at 298 K or 278 K in D2Ou s i n ga
Bruker Avance spectrometer. Chemical shifts are
reported in ppm referenced to DSS. Spectral assign-
ment was aided by recording of
1H 1D, gradient corre-
lation spectroscopy (COSY), TOCSY, (60 and 120 ms
mixing time),
13C attached proton test (APT),
1H-
13C-
HSQC and edited
1H-
13C-HSQC (CH and CH2 corre-
lations opposite sign),
1H-
13C-HSQC-TOCSY and edi-
ted
1H-
13C-HSQC-TOCSY (60 and 120 ms mixing
time) (one bond C-H correlations opposite sign), and
1H-
13C-HSQC-nuclear Overhauser enhancer spectro-
scopy (-NOESY), NOESY (400 ms) spectra. In addition,
1D selective TOCSY experiments were used to assist
w i t ht h ea s s i g n m e n tp r o c e s s .A l ls p e c t r aw e r ea c q u i r e d
using unmodified pulse sequences from the Bruker
p u l s es e q u e n c el i b r a r y .
Ligand and Western blotting
In addition to chemical staining, the fractionated C.
jejuni LOS was transferred from Tricine SDS-PAGE gels
onto a Pall® PVDF membrane using a semi-dry trans-
blotter (Bio-Rad). After transfer, the membrane was
reacted with horseradish peroxidase-(HRP-) conjugated
CTB (3 μgm L
-1), or with HRP-conjugated PNA (lectin
from Arachis hypogaea)( 5μgm L
-1), or with HRP-
conjugated anti-GM1 ganglioside IgG (diluted 1:3000) in
PBS. Membranes were developed using HRP Color
Development Solution (Bio-Rad) or SuperSignal HRP
Chemiluminescent Substrate (Thermo Scientific) accord-
ing to the manufacturer’s instructions.
Colony lift
C. jejuni was grown on Columbia agar containing 2%
(v/v) horse blood under microaerobic conditions as
described above. The lower concentration of blood was
used to reduce the background during the blotting pro-
cedure. Colonies were bound to the nitrocellulose mem-
brane by overlaying the agar plate. The membrane was
then baked for 1 h at 80°C as described elsewhere [40].
Subsequently, the membrane was blotted with HRP-
CTB as described above.
Amplification and sequencing of phase variable genes
wlaN and cj1144-45c
For PCR wlaN G-tract forward (GATATAGCTAAAGA
GTATGCTAGTAAAG) wlaN G-tract reverse (GGA-
TAATATAATAAGGCATCTTCTGCC) and cj1144-45c
G-tract forward (GGGTTGATGAAGCAAGAAATTAG-
TAG) cj1144-45c G-tract reverse (GCTAAAAACCA
AGGTCCTATAACACC) primer combinations wee
used. Twenty (20) reactions were inoculated with bac-
teria from single colonies of C. jejuni 11168-O grown at
42°C. Amplified ~500 bp fragments were cleaned up
using an Eppendrof Perfectprep Gel Cleanup kit and
were sent for sequencing at the Australian Genome
Research Facility (University of Queensland, St. Lucia,
Brisbane, QLD, Australia).
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